MUC-1 targeted Chimeric Antigen Receptor T Cells (CART) Therapy in Breast Cancer
Latest Information Update: 27 Feb 2018
At a glance
- Drugs Anti-MUC1 CAR-T cell therapy (Primary)
- Indications Brain metastases; Breast cancer
- Focus Therapeutic Use
- Sponsors Innovative Cellular Therapeutics
Most Recent Events
- 27 Feb 2018 New trial record